TY - JOUR
T1 - Retrospective analysis of alcohol testing in trauma team activation patients at a Canadian tertiary trauma centre
AU - Erdogan, Mete
AU - Kureshi, Nelofar
AU - Karim, Saleema A.
AU - Tallon, John M.
AU - Asbridge, Mark
AU - Green, Robert S.
N1 - Publisher Copyright:
© 2018 Author(s).
PY - 2018/11/1
Y1 - 2018/11/1
N2 - Objectives Although alcohol screening is an essential requirement of level I trauma centre accreditation, actual rates of compliance with mandatory alcohol testing in trauma patients are seldom reported. Our objective was to determine the prevalence of blood alcohol concentration (BAC) testing in patients requiring trauma team activation (TTA) for whom blood alcohol testing was mandatory, and to elucidate patient-level, injury-level and system-level factors associated with BAC testing. Design Retrospective cohort study. Setting Tertiary trauma centre in Halifax, Canada. Participants 2306 trauma patients who required activation of the trauma team. Primary outcome measure The primary outcome was the rate of BAC testing among TTA patients. Trends in BAC testing over time and across patient and injury characteristics were described. Multivariable logistic regression examined patient-level, injury-level and system-level factors associated with testing. Results Overall, 61% of TTA patients received BAC testing despite existence of a mandatory testing protocol. Rates of BAC testing rose steadily over the study period from 33% in 2000 to 85% in 2010. Testing varied considerably across patient-level, injury-level and system-level characteristics. Key factors associated with testing were male gender, younger age, lower Injury Severity Score, scene Glasgow Coma Scale score <9, direct transport to hospital and presentation between midnight and 09:00 hours, or on the weekend. Conclusions At this tertiary trauma centre with a policy of empirical alcohol testing for TTA patients, BAC testing rates varied significantly over the 11-year study period and distinct factors were associated with alcohol testing in TTA patients.
AB - Objectives Although alcohol screening is an essential requirement of level I trauma centre accreditation, actual rates of compliance with mandatory alcohol testing in trauma patients are seldom reported. Our objective was to determine the prevalence of blood alcohol concentration (BAC) testing in patients requiring trauma team activation (TTA) for whom blood alcohol testing was mandatory, and to elucidate patient-level, injury-level and system-level factors associated with BAC testing. Design Retrospective cohort study. Setting Tertiary trauma centre in Halifax, Canada. Participants 2306 trauma patients who required activation of the trauma team. Primary outcome measure The primary outcome was the rate of BAC testing among TTA patients. Trends in BAC testing over time and across patient and injury characteristics were described. Multivariable logistic regression examined patient-level, injury-level and system-level factors associated with testing. Results Overall, 61% of TTA patients received BAC testing despite existence of a mandatory testing protocol. Rates of BAC testing rose steadily over the study period from 33% in 2000 to 85% in 2010. Testing varied considerably across patient-level, injury-level and system-level characteristics. Key factors associated with testing were male gender, younger age, lower Injury Severity Score, scene Glasgow Coma Scale score <9, direct transport to hospital and presentation between midnight and 09:00 hours, or on the weekend. Conclusions At this tertiary trauma centre with a policy of empirical alcohol testing for TTA patients, BAC testing rates varied significantly over the 11-year study period and distinct factors were associated with alcohol testing in TTA patients.
UR - http://www.scopus.com/inward/record.url?scp=85056575833&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85056575833&partnerID=8YFLogxK
U2 - 10.1136/bmjopen-2018-024190
DO - 10.1136/bmjopen-2018-024190
M3 - Article
C2 - 30429147
AN - SCOPUS:85056575833
SN - 2044-6055
VL - 8
JO - BMJ Open
JF - BMJ Open
IS - 11
M1 - e024190
ER -